Regenity Biosciences advances new frontiers in regenerative science, turning bioabsorbable materials into life-changing solutions. Sought after for our novel resorbable technologies and distinct approach to contract manufacturing and contract development, our team brings the urgency and vision to deliver breakthrough medtech solutions for medical technology and medical device manufacturers of all sizes.
As part of our vision to be the global leader in bioresorbable technologies for tissue and bone repair, we’ve rebranded as Regenity Biosciences. We’re also excited to share that we’ve acquired Polyganics. This has expanded our portfolio with versatile bioresorbable and biocompatible synthetic polymers to repair natural tissue across ENT, neurosurgery, and general surgery applications.
Patients depend on us delivering our products with enthusiasm, efficiency, and diligence. Our obligation and privilege is to drive urgency on patients’ behalf.
We are passionate trailblazers, relentless in our pursuit of continuous improvement.
We are passionate, dedicated, and tenacious about our goals.
We act in all ways with respect and transparency, ethically and honestly, with everyone. Our work represents who we are, as we create products we can proudly recommend to our loved ones.
We are only successful together, operating as one diverse and inclusive team with each other and our customers.
There’s an art and a science to regenerative science. Our scientists and inventors transform tissue healing, from product concept through commercialization. As subject matter experts in material production and processing, product development, and manufacturing, we design and produce advanced devices and implants that support the body’s natural ability to regenerate.
For more than 25 years, Regenity has supported clients around the world looking to accelerate time-to-market, augment their product portfolio, create new innovations, manufacture new products, and gain regulatory approval. We offer a vast array of raw materials, contract manufacturing, and contract development solutions for medical technology clients.
Applying our state-of-the-art proprietary technology platforms, we develop bioresorbable and biocompatible materials for use in a range of medical and dental applications, driving tissue regeneration and functional patient recovery.
Medical device approvals in 86 countries
Devices a year delivered to medical technology clients
Devices produced since inception
Read about our latest news, and download available product brochures.
The rebrand supports the company’s position as material transformers in regenerative implant…
We are excited to honor and celebrate our Vice President of R&D Dan Ammon and his recent…
We are pleased to announce the appointment of Charles (Chip) Ross as Vice President of Human…
We are pleased to announce the appointment of Tim Starr as Chief Operating Officer at Collagen…
The Investment Expands CMI’s Regenerative Medicine Portfolio, R&D Capabilities and…
OAKLAND, NJ — 6/28/22 — Collagen Matrix, Inc., a leader in regenerative medicine, global…
Collagen Matrix Inc., a leader in regenerative medicine, global manufacturer of collagen and…
Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical…
Looking for a career with purpose? Join our team and work with us to develop life-changing products that help patients heal. Visit our careers page to learn more about what sets Regenity apart.